Inflammatory Biomarkers
Physical Findings
Imeka receives investment from ADDF to develop novel biomarkers for Alzheimer’s disease
A Canadian neuroimaging company has received an investment from the Alzheimer’s Drug Discovery Foundation to accelerate development of novel biomarkers for Alzheimer’s disease and related dementias.
Q&A: CD6/ALCAM may hold key to more specific, effective therapies in lupus nephritis
Uncovering a viable biomarker in a historically challenging disease like lupus nephritis is tantamount to striking gold if it can be used for one important purpose: Predicting treatment response.
Epigenetic biomarker may reliably measure impact of chronic inflammation on brain
Chronic inflammation appeared linked to neurodegenerative brain changes that affect cognitive ability differences in later life, according to study results published in Neurology.
VIDEO: Skyrizi induces clinical remission, endoscopic response in Crohn’s
LAS VEGAS – Patients dosed with Skyrizi for Crohn’s disease achieved clinical remission, endoscopic response and persistent improvements to inflammatory biomarkers consistent with a dose-response relationship.